Abstract
Membranoproliferative Glomerulonephritis (MPGN) is one of the important causes of end-stage kidney disease (ESKD), leading to kidney transplants. Moreover, the occurrence of MPGN in kidney allograft negatively impacts its survival. The reclassification of MPGN with immunofluorescence has transformed the way we diagnose and treat the condition in kidney transplant recipients. The optimal treatment of post-transplant idiopathic immune complex-mediated MPGN (IC-MPGN) is not established. In this chapter, we have attempted to highlight a classic case of de novo idiopathic IC-MPGN in a kidney allograft recipient. He achieved successful remission with rituximab and appropriate up-titration of immunosuppression.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Alasfar S, Carter-Monroe N, Rosenberg AZ, Montgomery RA, Alachkar N. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification. BMC Nephrol. 2016;17:7.
RJ G. Membranoproliferative glomerulonephritis. In: Molony DA CJ, editor. Evidence-based nephrology. London: Wiley-Blackwell; 2009. p. 183–96.
Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol. 2011;31(4):341–8.
Denton MD, Singh AK. Recurrent and de novo glomerulonephritis in the renal allograft. Semin Nephrol. 2000;20(2):164–75.
Floege J. Recurrent glomerulonephritis following renal transplantation: an update. Nephrol Dial Transplant. 2003;18(7):1260–5.
Mathew TH. Recurrence of disease following renal transplantation. Am J Kidney Dis. 1988;12(2):85–96.
Cameron JS. Glomerulonephritis in renal transplants. Transplantation. 1982;34(5):237–45.
Glicklich D, Matas AJ, Sablay LB, Senitzer D, Tellis VA, Soberman R, et al. Recurrent membranoproliferative glomerulonephritis type 1 in successive renal transplants. Am J Nephrol. 1987;7(2):143–9.
Andresdottir MB, Assmann KJ, Hoitsma AJ, Koene RA, Wetzels JF. Recurrence of type I membranoproliferative glomerulonephritis after renal transplantation: analysis of the incidence, risk factors, and impact on graft survival. Transplantation. 1997;63(11):1628–33.
Habib R, Antignac C, Hinglais N, Gagnadoux MF, Broyer M. Glomerular lesions in the transplanted kidney in children. Am J Kidney Dis. 1987;10(3):198–207.
Little MA, Dupont P, Campbell E, Dorman A, Walshe JJ. Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk. Kidney Int. 2006;69(3):504–11.
Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, et al. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int. 2017;92(2):461–9.
Moroni G, Casati C, Quaglini S, Gallelli B, Banfi G, Montagnino G, et al. Membranoproliferative glomerulonephritis type I in renal transplantation patients: a single-center study of a cohort of 68 renal transplants followed up for 11 years. Transplantation. 2011;91(11):1233–9.
Green H, Rahamimov R, Rozen-Zvi B, Pertzov B, Tobar A, Lichtenberg S, et al. Recurrent membranoproliferative glomerulonephritis type I after kidney transplantation: a 17-year single-center experience. Transplantation. 2015;99(6):1172–7.
Lorenz EC, Sethi S, Leung N, Dispenzieri A, Fervenza FC, Cosio FG. Recurrent membranoproliferative glomerulonephritis after kidney transplantation. Kidney Int. 2010;77(8):721–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Chauhan, K., Aziz, F. (2022). Post-Transplant Idiopathic Immune Complex Glomerulonephritis. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_40
Download citation
DOI: https://doi.org/10.1007/978-3-031-13569-9_40
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13568-2
Online ISBN: 978-3-031-13569-9
eBook Packages: MedicineMedicine (R0)